SYLATRON™ (peginterferon alfa-2b) for injection, for subcutaneous use

First Page		Document Content
Date: 2012-12-28 10:56:59 Health Cytokines Interferon Alcohols Ribavirin Adverse effect Hepatitis C and HIV co-infection Iloprost Antivirals Medicine Chemistry		SYLATRON™ (peginterferon alfa-2b) for injection, for subcutaneous use Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 459,61 KB Share Document on Facebook

	Cardiovascular Medicine Kardiovaskuläre Medizin / Médecine cardiovasculaire Supplementum 21 ad Cardiovascular Medicine 2012;15(5) DocID: 1plJD - View Document
	OPEN ACCESS Research Article Perioperative management of patients with severe pulmonary hypertension in major orthopedic surgery: DocID: 1ghGA - View Document
	AARC Clinical Practice Guideline Aerosol Delivery Device Selection for Spontaneously Breathing Patients: 2012 Arzu Ari PhD RRT PT CPFT FAARC and Ruben D Restrepo MD RRT FAARC Using an electronic literature search for pu DocID: 1aet0 - View Document
	IN THIS ISSUE: A Focus on Pharmacy, Pharmacology and Pulmonary Hypertension Click on titles below to jump to article Introduction and Mission of the Pharmacy and Pharmacology Council Patricia Uber, PharmD DocID: 1a91j - View Document
	ventavis logo_GREY_no inhaled_ƒ_® DocID: 13tKu - View Document